Rates of glaucomatous visual field change in a large clinical population

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 7, 2014, Pages 4135-4143

  Chauhan, Balwantray C ^a   Malik, Rizwan ^a   Shuba, Lesya M ^a   Rafuse, Paul E ^a   Nicolela, Marcelo T ^a   Artes, Paul H ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Clinical study; Glaucoma; Progression; Visual field

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DISEASE COURSE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; PERIMETRY; PRIORITY JOURNAL; TERMINAL DISEASE; TERTIARY CARE CENTER; VISUAL FIELD;

CLINICAL STUDY; GLAUCOMA; PROGRESSION; VISUAL FIELD;

AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NOVA SCOTIA; PREVALENCE; PROGNOSIS; SCOTOMA; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84903973556     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14643     Document Type: Article

References (40)

1. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279
2. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713, discussion 829-730
3. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487-497
4. Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I. Results of the European Glaucoma Prevention Study. Ophthalmology. 2005;112:366-375
5. Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology. 2009;116:200-207
6. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-440
7. Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE. Canadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008; 126:1030-1036
8. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol. 1991;111:51-55
9. Martinez-Bello C, Chauhan BC, Nicolela MT, McCormick TA, LeBlanc RP. Intraocular pressure and progression of glaucomatous visual field loss. Am J Ophthalmol. 2000;129:302-308
10. De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T. Risk factors for visual field progression in the low-pressure glaucoma treatment study. Am J Ophthalmol. 2012;154:702-711
11. Heijl A, Bengtsson B, Hyman L, Leske MC. Natural history of open-angle glaucoma. Ophthalmology. 2009;116:2271-2276
12. O'Brien C, Schwartz B, Takamoto T, Wu DC. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol. 1991;111:491-500
13. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419-1428
14. Rasker MT, van den Enden A, Bakker D, Hoyng PF. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol. 2000;118:481-488
15. Kwon YH, Kim CS, Zimmerman MB, Alward WL, Hayreh SS. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol. 2001;132: 47-56
16. Chauhan BC, Nicolela MT, Artes PH. Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma. Ophthalmology. 2009;116:2110-2118
17. Leung CK, Liu S, Weinreb RN, et al. Evaluation of retinal nerve fiber layer progression in glaucoma a prospective analysis with neuroretinal rim and visual field progression. Ophthalmology. 2011;118:1551-1557
18. Medeiros FA, Alencar LM, Sample PA, Zangwill LM, Susanna R Jr, Weinreb RN. The relationship between intraocular pressure reduction and rates of progressive visual field loss in eyes with optic disc hemorrhage. Ophthalmology. 2010;117:2061-2066
19. Schwartz B, Takamoto T, Martin J. Increased rate of visual field loss associated with larger initial visual field threshold values on follow-up of open-angle glaucoma. J Glaucoma. 2004;13: 120-129
20. Chauhan BC, Mikelberg FS, Artes PH, et al. Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change. Arch Ophthalmol. 2010;128:1249-1255
21. Anderson DR, Drance SM, Schulzer M. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108:247-253
22. Henson DB, Shambhu S. Relative risk of progressive glaucomatous visual field loss in patients enrolled and not enrolled in a prospective longitudinal study. Arch Ophthalmol. 2006; 124:1405-1408
23. Heijl A, Buchholz P, Norrgren G, Bengtsson B. Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol. 2013;91:406-412
24. Canadian Glaucoma Study: 1. Study design, baseline characteristics, and preliminary analyses. Can J Ophthalmol. 2006; 41:566-575
25. Dixon WJ. Aspects of robust linear regression. Ann Stat. 1993; 21:1843-1899
26. Garway-Heath DF, Poinoosawmy D, Fitzke FW, Hitchings RA. Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology. 2000;107:1809-1815
27. Chauhan BC, Garway-Heath DF, Goni FJ, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92:569-573
28. Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145: 343-353
29. Artes PH, O'Leary N, Hutchison DM, et al. Properties of the statpac visual field index. Invest Ophthalmol Vis Sci. 2011;52: 4030-4038
30. Rao HL, Senthil S, Choudhari NS, Mandal AK, Garudadri CS. Behavior of visual field index in advanced glaucoma. Invest Ophthalmol Vis Sci. 2013;54:307-312
31. Lee JM, Cirineo N, Ramanathan M, et al. Performance of the visual field index in glaucoma patients with moderately advanced visual field loss. Am J Ophthalmol. 2014;157:39-43
32. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965-1972
33. Gordon MO, Torri V, Miglior S, et al. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology. 2007; 114:10-19
34. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627-1635
35. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131:699-708
36. Bengtsson B, Leske MC, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:205-209
37. De Moraes CG, Juthani VJ, Liebmann JM, et al. Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol. 2011;129:562-568
38. Forchheimer I, de Moraes CG, Teng CC, et al. Baseline mean deviation and rates of visual field change in treated glaucoma patients. Eye (Lond). 2011;25:626-632
39. Redmond T, O'Leary N, Hutchison DM, Nicolela MT, Artes PH, Chauhan BC. Visual field progression with frequency-doubling matrix perimetry and standard automated perimetry in patients with glaucoma and in healthy controls. JAMA Ophthalmol. 2013;131:1565-1572
40. Johnson CA, Adams AJ, Lewis RA. Evidence for a neural basis of age-related visual field loss in normal observers. Invest Ophthalmol Vis Sci. 1989;30:2056-2064